Home / Stocks / LYEL

LYEL insider trading

Lyell Immunopharma, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$450k
Buys · last 90 days
0 · $0
Most recent buy
2025-04-02

Cluster buy detected

5 insiders bought LYEL within a short window (2025-03-14→2025-03-31), $450k in total — cluster score 83/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-04-02BRAWLEY OTIS Wcluster
Director
Bought35,640$0.56$20k
2025-03-25Ramachandra Sumantcluster
Director
Bought200,000$0.58$116k
2025-03-18Klausner Richardcluster
Director
Bought158,000$0.60$95k
2025-03-18Seely Lynncluster
President and CEO
Bought175,000$0.61$107k
2025-03-18Newton Charles W.cluster
Chief Financial Officer
Bought200,000$0.56$112k

Most active insider buyers

InsiderRoleBuysTotal bought
Ramachandra SumantDirector1$116k
Newton Charles W.Chief Financial Officer1$112k
Seely LynnPresident and CEO1$107k
Klausner RichardDirector1$95k
BRAWLEY OTIS WDirector1$20k

See LYEL on the chart

Every insider buy and sell for LYEL plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.